Legal Representation
Attorney
John L. DuPre'
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 3, 2013 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 3, 2013 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Sep 5, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 5, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 5, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 29, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2012 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 15, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 11, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of the aforesaid diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005